The occurrence of acute urticaria during treatment with drugs is a frequent
event which poses two problems: 1) is the urticaria connected with the dru
g administration or with the underlying pathology which led to the prescrip
tion of the drug; 2) is the urticaria allergic in origin, i.e, due to speci
fic immunity triggers, in particular IgE directed against the drug, or is t
he urticaria pseudo-allergic in origin, i.e. due to non-specific activation
of mastocytes [1]? This question is of major importance because allergic e
vents caused by IgE are potentially fatal while pseudo-allergic events are
only rarely life-threatening. In this article we will not deal with contact
urticaria where the cause is easily identifiable [2].